Autoimmune Encephalitis, 23D07 - 11/29/2022

Tuesday, November 29, 2022, 8:00 AM - 9:00 AM, Zoom Videoconference

The Neurology department is composed of a diverse group of faculty members. Some practice neurology while others are sub-specialists who are experts in their field. We also have Advanced Practice Providers, residents, fellow(s) and students from OU College of Medicine. Our aim is to provide sessions which are of value to this diverse group of attendees, providing a mix of common and uncommon neurological conditions, while also including sessions targeting quality improvement, provider wellness and professional development. Each session is 1 hour long, with a question-answer session included at the end.

Overall Program Professional Practice Gaps:
1.  Guides to new anti-epileptic medications: There is a lack of knowledge regarding the newer anti-epileptic medications, their side effects and rationiale for appropriate utilization even in general neurologists.
2.  Frontotemporal dementia and Lewy Body dementia: Most neurologists are comfortable with Alzheimer's disease and vascular dementia, however, diagnosis and management of frontotemporal dementia (FTD) and Lewy Body Dementia remains challenging.
3. Restless leg syndrome: Restless leg syndrome is a common movement disorder in the general population, however, it is still frequently misdiagnosed, under diagnosed and under treated.
4. Infectious encephalitis: Most practicing neurologists and neurohospitalists encounter infective encephalitis. While some of these entities are well recognized, there are many uncommon etiological factors which remain under diagnosed.

Session Professional Practice Gap:  
There is Incomplete understanding of clinical presentation and treatment of autoimmune encephalitis.
Often there is overdiagnosis or underdiagnosis of autoimmune encephalitis leading to detrimental clinical outcome.

Learning Objectives:  Upon completion of this session, participants will improve their competence and performance by being able to:
Describe clinical presentation and diagnostic work-up for autoimmune encephalitis.
List pitfalls/differential diagnosis of autoimmune encephalitis.
Review treatment approach for autoimmune encephalitis.

Download Announcement

1. Describe clinical presentation and diagnostic work-up for autoimmune encephalitis.
2. List pitfalls/differential diagnosis of autoimmune encephalitis.
3. Review treatment approach for autoimmune encephalitis.

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides. Inquiries regarding non-discrimination policies may be directed to: Shaniqua Crawford, JD, Institutional Equity Officer and Title IX Coordinator, 405-325-3546, [email protected], or visit www.ou.edu/eoo.html. 

Accommodation Statement:
Accommodations on the basis of disability are available by contacting (insert Course Contact) at (405) xxx-xxxx or (insert email address) as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.